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To the Editor: Extraintestinal patho­
genic Escherichia coli (ExPEC) strains are 
versatile bacteria that have the ability 
to cause human extraintestinal infections 
such as urinary tract infections, neonatal 
meningitis, and sepsis worldwide.[1] They 
lead to significant medical and societal 
costs in both healthcare and community 
settings. ExPEC are known for their 
extensive intrinsic virulence potential 
based on the number and diversity of 
specific putative or proven virulence 
genes regardless of their isolation source. 
They usually inhabit the intestinal 
microbiome of humans and animals, from 
which they can subsequently emerge to 
cause extraintestinal infections. There is 
therefore a thin line between the non­
pathogenic commensal E. coli and ExPEC 
strains, and it has been hypothesised that 
ExPEC virulence may be a by­product 
of the commensal lifestyle.[2] In addition, 
the emergence of the extended­spectrum 
beta­lactamase (ESBL) genes encoding for 
resistance to beta­lactam antibiotics has 
exacerbated their pathogenicity.
A total of 432 rectal and nasal samples 
from pigs collected from 5 abattoirs 
(3 in Cameroon and 2 in South Africa 
(SA)) were phenotypically screened and 
tested for antimicrobial susceptibility, 
with a selected subsample undergoing 
whole­genome sequencing (WGS) and 
bioinformatics analysis as previously 
described.[3] The Comprehensive Anti­
biotic Resistance Database (CARD), 
ResFinder, VirulenceFinder, VFanalyzer, 
MGEFinder and PlasmidFinder were used 
to identify resistance genes, virulence 
factors, mobile genetic elements and 
plasmids, respectively. The multilocus 
sequence type (MLST) was also deter­
mined from WGS data.
One of the ESBL­producing E. coli 
isolates, PN254E (GenBank accession 
number VKOR00000000), showed 
resistance to beta­lactam and non­
beta­lactam antibiotics. This resistance 
phenotype was corroborated by the 
identification of the blaCTX­M­1 and 
blaCTX­M­14 genes through WGS, which also 
delineated a collection of resistance genes 
encoding target modification, antibiotic 
inactivation, antibiotic efflux pumps and 
regulators (Table 1). The PN254E isolate 
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MLST alleles and was ascribed to the sequence type (ST) 221 and 
serotype O34:H9. It further harboured several virulence factors 
including the ferric aerobactin receptor (iutA),  increased serum 
survival (iss),  heat­resistant agglutinin (hra), temperature­sensitive 
haemagglutinin (tsh), P fimbrial adhesin (papA, papC, papD, papX), 
type I fimbriae (fimA, fimB, fimD, fimE, fimF, fimG, fimI), F1C 
fimbriae (focC, focD, focG, focH, focI), salmochelin siderophore 
(iroN), yersiniabactin siderophore (fyuA) and haemolysin HlyA 
that are commonly detected in several E. coli strains responsible 
for human extraintestinal infections. Numerous mobile genetic 
elements such as the IncFIB(AP001918 [F89:A­:B1]), IncI1 (ST3), 
and IncHI2 (unknown ST) plasmid incompatibility groups, the high­
pathogenicity island (HPI), the transposon Tn6082 and an array of 
insertion sequences were also detected, as shown in Table 1.
To the best of our knowledge, this is the first report on the 
presence of an ExPEC ST221­fimH9 serotype O34:H9 harbouring 
the HPI, hypervirulent plasmid IncI1 ST3, and over 100 virulence 
factors isolated from the swine microbiome in SA, and indeed in 
Africa. Our report clearly shows that the gut microbiome of swine 
is also a reservoir of ESBL­producing ExPEC and a potential source 
of virulence and resistance genes that may be transferred to other 
bacteria prevailing in the microbiome. The combination of virulence 
and drug resistance in pathogenic bacteria highlights the worrisome 
situation of a likely dearth of therapeutic alternatives for some 
serious bacterial infections in the near future. This phenomenon, 
coupled with high prevalence of immunocompromised individuals 
in the sub­Saharan African region, calls for increased surveillance 
of the population structure of ExPEC in order to preserve the 
general public from highly virulent and resistant bacterial infections. 
Stringent efforts to ensure rational antibiotic use in agriculture are 
a further imperative to safeguard and preserve antibiotics for future 
generations.
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